Matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis identified enolase as a cell surface component of Streptococcus mutans, which was confirmed by enzyme-linked immunosorbent assay, Western blotting, and transmission electron microscopy. Surface enolase was demonstrated to bind to human plasminogen and salivary mucin MG2. The results suggested a role for enolase in S. mutans attachment, clearance, or breach of the bloodstream barrier.
Western blot, TEM, and ELISA experiments demonstrate that S. mutans surface enolase binds to human plasminogen and human salivary mucin MG2.
S. mutans A32-2 was isolated from a highly-caries-active patient and expresses significantly more surface proteins than isolates from caries-free subjects (26) . Surface protein, cell wall, and cytoplasmic samples were purified according to methods described previously (17, 24, 26) . Briefly, S. mutans was harvested, washed in surface protein buffer (10 mM phosphate-buffered saline, 1 mM CaCl 2 , pH 7.2, 1% phenylmethylsulfonyl fluoride), and sheared in a Waring blender for three 1-min cycles at high speed. The unbroken cells and debris were removed by centrifugation at 10,000 ϫ g for 10 min at 4°C. The supernatant containing surface proteins was centrifuged at 16,000 ϫ g for 15 min at 4°C, transferred to a fresh tube, and centrifuged again at 110,000 ϫ g for 2.5 h at 4°C. The pellet containing the surface proteins was resuspended in surface protein buffer and stored at Ϫ80°C. Cytoplasmic and cell wall fractions were collected from disrupted cells by a sucrose gradient. Protein concentrations of all preparations were measured by a QuantiPro bicinchoninic acid assay kit (Sigma).
S. mutans subcellular samples or saliva components were separated by sodium dodecyl sulfate (SDS)-PAGE (7.5% polyacrylamide). MALDI-TOF MS was performed on trypsin-digested, Coomassie stained spots excised from surface proteins separated on two-dimensional PAGE gels (32) at the Biochemistry Biotechnology Facility (Dept. of Biochemistry, Indiana University School of Medicine). About 160 spots from the gel were visualized by computer-generated imaging, and 96 spots were analyzed by MALDI-TOF MS with Profound software (34) (http://129.85.19.192/profound_bin/WebProFound .exe), based on Z value and coverage percentage (data not shown). Two spots with molecular masses of 47 and 60 kDa and pIs of pIs 4.7 and 6.0, respectively, were identified as enolase. Enolase is predicted to be encoded by a single-copy gene designated SMU.1247 (1) . Around 67% of the smaller enolase peptide mass matched the computed enolase mass using the top 50 MALDI-TOF peptides, and the Z value was 2.36. Around 38% of the larger measured enolase peptide mass matched the computed enolase mass using the top 50 MALDI-TOF peptides, and the Z value was 1.65. Modification of each protein was also predicted based on the MALDI-TOF (5, 7) . Our analysis of the enolase peptide sequence of S. mutans suggests the possibility of phosphorylation sites based on the MALDI-TOF data. Phosphorylation can affect protein-protein interactions (6) , and phosphorylated enolase may bind to the receptor on the cell surface.
Bacterial samples for immunogold bead staining were prepared for TEM (http://www.nanoprobes.com/Inf2016.html) to study the presence of surface enolase on S. mutans and its binding ability to human plasminogen Far-Western blot analysis (14) was used to study the binding ability of enolase to human plasminogen and mucin MG2. Enolase in the cell surface, cell wall, and cytoplasmic samples reacted with anti-␣-enolase antibody (1:300) in Western blots (Fig. 1A) . Enolase (47 kDa) in the cell surface, cell wall, and cytoplasmic fractions binds plasminogen (0.02 mg/ml; Fig. 1B ). Cytoplasmic enolase binding with plasminogen was most intense in Fig. 1B , while cell wall enolase reacting with antienolase antibody was most intense in Fig. 1A . Since antienolase antibody is polyclonal, it can recognize multiple domains of the enolase molecule and may recognize domains of cell wall enolase molecules with high efficiency. Plasminogen recognizes only C-terminal lysines (8) , and since the concentration of enolase in cytoplasm was higher than that in the other samples, this produced a more intense band. The binding of enolase to plasminogen can be blocked by antienolase antibody (Fig. 1C) . Negative controls were not incubated with plasminogen or antiplasminogen antibody, and there was no band in the negative controls.
To investigate the binding of salivary proteins to enolase, electrophoretically separated salivary proteins (saliva supernatant from laboratory volunteers; Institutional Review Board approval) were transferred to the polyvinylidene difluoride (PVDF) membrane and incubated with purified enolase (0.05 mg/ml; Sigma) followed by incubation with antienolase antibody (1:200). Enolase interacted with only one protein, with a molecular mass of 180 kDa ( Fig. 2A ). Schiff's staining of the salivary proteins indicated the 180-kDa protein was a highly glycosylated protein (results not shown), and the Western blots of salivary proteins incubated with anti-mucin MG2 antibody (1:1,000; Laboratory of Biochemistry, Boston University) demonstrated that the 180-kDa protein was mucin MG2 (Fig. 2A) . Separated subcellular proteins, when incubated with salivary supernatant (containing mucins MG1 and MG2) followed by incubation with anti-mucin MG2 antibody, confirmed enolase in subcellular samples binding to salivary mucin MG2 (Fig.  2B) . Negative controls were not incubated with saliva supernatant or anti-mucin MG2 antibody, and there was no band in the negative controls. The interaction was confirmed by coimmunoprecipitation (results not shown). The complex, formed by mixing the S. mutans subcellular samples with salivary proteins, was purified with anti-␥-enolase antibody (1:200) and protein A (10 l; Sigma). Mucin MG2 in the complex was confirmed with anti-mucin MG2 antibody (1:1,000) in Western blot analysis.
ELISA was used to assess enolase localization and the ability of enolase to bind human plasminogen and mucins MG1 and MG2. ELISA confirmed that not only was enolase present in the cytoplasmic fraction as expected, it was also observed in the cell surface fraction (Fig. 3) . As expected, ␣-enolase reacted (C) Surface protein, cell wall, and cytoplasm samples were incubated with blocking rabbit anti-enolase antibody (1:300) and centrifuged. The supernatants of those samples were isolated by SDS-PAGE and transferred to a PVDF membrane, which was incubated with plasminogen (0.02 mg/ml), goat anti-plasminogen, and anti-goat IgG-peroxidase (1:500). The binding activity of enolase with plasminogen was decreased by blocking rabbit anti-enolase antibody. with anti-␣-enolase (1:500) and anti-␥-enolase antibodies (1: 500; Sigma), while the no-antibody negative controls did not. The data were analyzed by Student's t test. The version for independent samples was used. The variances in the groups were assumed to be equal, and the test was two sided. The P values of all groups were Ͻ0.05, which means there are significant differences between experimental groups and control groups. The presence of enolase in the culture supernatant suggested either an active secretion of enolase or the presence of lysed bacterial cells. ELISA plates were coated with anti-␣ enolase antibody (1:500), which bound enolase in surface, cell wall, and cytoplasm samples. Enolase subsequently reacted with human plasminogen (0.02 mg/ml), which was detected by incubation with goat anti-human plasminogen antibody (1:1,000) followed by peroxidase-conjugated anti-goat IgG antibody (1:1,000; Sigma), while the no-plasminogen controls were negative. The data were analyzed by t test as described before, and the P values of all groups were Ͻ0.05. ELISA results supported the conclusion that S. mutans surface enolase can bind to human plasminogen (Fig. 4) . In a similar experiment, the plate was coated with S. mutans subcellular samples, incubated with saliva supernatant, and reacted with anti-mucin MG1 or anti-mucin MG2 antibodies (1:1,000). The data were analyzed by t test, and the P values were Ͻ0.05. ELISA results indicated that proteins in the subcellular samples reacted with both mucins MG1 and MG2 (Fig. 4) . Combining the ELISA data with the Western blot in Fig. 2 confirmed that enolase in the subcellular samples reacted with salivary mucin MG2. Wistedt et al. (33) found that proteins presenting exposed 1,000) . Following color development, the absorbance of each well was measured at 490 nm. The data were analyzed by Student's t test (independent samples with equal variances and two sides), and the P values of all groups were Ͻ0.05.
FIG. 4. Ability of S. mutans
enolase to bind to plasminogen and salivary mucins MG1 and MG2. The ability of enolase in surface protein (SP), cell wall (CW), and cytoplasm (Cyto) samples to bind to human plasminogen was detected by ELISA. An ELISA plate was coated with rabbit anti-enolase antibody (1:500) and incubated with sequentially subcellular samples of plasminogen (Pla; 0.02 mg/ml), goat anti-plasminogen antibody (1:1,000), and anti-goat IgG conjugated with peroxidase (1:1,000). In a similar experiment, proteins in the subcellular samples able to bind to human salivary mucins MG1 and MG2 were detected by ELISA. An ELISA plate was coated with subcellular samples (surface protein, cell wall, and cytoplasm samples), incubated sequentially with saliva supernatant (containing salivary mucins MG1 and MG2), rabbit anti-mucin MG1 (1:1,000) or anti-mucin MG2 antibodies (1:1,000), and anti-rabbit IgG conjugated with peroxidase (1:1,000). Following color development, the absorbance of each well was measured at 490 nm. The data were analyzed by Student's t test (independent samples with equal variances and two sides), and the P values of all groups were Ͻ0.05. (31) . In addition, there is similarity between streptococcal enolase and human enolase (49% identity). Because of the similarity between human and streptococcal enolase, antienolase antibodies reactive with human enolase are produced after S. pyogenes infection (10) . Furthermore, in some autoimmune diseases, antienolase antibodies have been identified (10, 28) . Similarly, cross-reactivity of human enolase with antibodies specific for S. mutans surface enolase may play a role in pathophysiological processes. Mucins MG1 and MG2 are highly glycosylated proteins, which can form heterotypic complexes with other salivary proteins in nonglycosylated regions (22) . Mucin MG1 can bind to amylase, proline-rich proteins, statherin, and histatins, and mucin MG2 can bind to SIgA and lactoferrin (4, 29) . Mucin MG2 protects lactoferrin from proteolytic attack, and the interaction of mucin MG2 with oral bacteria exhibits bactericidal activity (29) . Mucin MG2 was observed to bind to some unknown surface components of S. mutans (18) . Our results indicate that surface enolase is one ligand responsible for the binding of salivary mucin MG2 to S. mutans. Soluble mucin MG2 may serve as a bridge between S. mutans and other salivary proteins. The interaction of surface enolase with mucin MG2 may either lead to bacterial attachment to oral tissues or facilitate the removal of S. mutans from the oral cavity.
This paper describes the identification of enolase as a component of S. mutans surface proteins and demonstrates the binding of surface enolase to human plasminogen. Additionally, this is the first report that a bacterial surface enolase interacts with the human salivary component mucin MG2. Further studies will be needed to define the role of enolase in the virulence of S. mutans.
